Shares of Boston Scientific Corporation were little changed after the company announced that it has completed the acquisition of Asthmatx, Inc. BSX purchased all outstanding Asthatx shares for $193.5 million.
Boston Scientific Corporation specializes in medical specialities. They market, manufacture, and develop medical devices.
